IL6 and Arthritis: For example, in the CIA mouse model and RA patients, the HDAC6 selective inhibitor, CKD-L, inhibits IL-6, TNF-α, and IL-1β expression, and increases IL-10 production, resulting in a decreased arthritis score and inhibited proliferation of effector T cells [22].